Digital Investments And Insurtech Adoption Will Shape Resilient Non-Life Markets

AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Published
07 Nov 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
€9.85
0.8% undervalued intrinsic discount
07 Aug
€9.77
Loading
1Y
21.2%
7D
4.3%

Author's Valuation

€9.9

0.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 9.96%

Shared on23 Apr 25
Fair value Decreased 0.22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.67%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.22%

AnalystConsensusTarget has decreased revenue growth from 1.2% to 0.9%.

Shared on19 Mar 25
Fair value Increased 0.23%

AnalystConsensusTarget has decreased revenue growth from -0.5% to 1.2%.

Shared on12 Mar 25
Fair value Decreased 6.85%

AnalystConsensusTarget has decreased revenue growth from -5.0% to -0.5%, decreased profit margin from 18.6% to 15.7% and increased future PE multiple from 18.1x to 23.4x.